Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|NX-2127||NX 2127|NX2127||BTK inhibitor 28||NX-2127 is a small molecule that induces degradation of BTK, which may lead to inhibition of the growth of malignant B-cells (62nd ASH Annual Meeting and Exposition, Dec 2020, Abstract 2788).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04830137||Phase I||NX-2127||A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies||Recruiting||USA||0|